Project SyndicateへのPeter Singerの投稿から。

To seek an answer, we can turn to a country that we do not usually think of as a leader in either market deregulation or social experimentation: Iran. Since 1988, Iran has had a government-funded, regulated system for purchasing kidneys. A charitable association of patients arranges the transaction, for a set price, and no one except the seller profits from it.

According to a study published in 2006 by Iranian kidney specialists, the scheme has eliminated the waiting list for kidneys in that country, without giving rise to ethical problems. A 2006 BBC television program showed many potential donors turned away because they did not meet strict age criteria, and others who were required to visit a psychologist.

イランでは腎臓売買の手配・価格の設定などを行う国家認定の組織が存在し、現在では腎臓移植を待っている人は存在しないそうだ。言及されているBBCのプログラムの内容はこちらで見られる（番組のスクリプトはこちら）。またより詳細な説明がこちらにあった。

Those who volunteer to donate the kidney to unrelated recipient; government gives him cash compensation equivalent of 6 months of his salary, lifetime health insurance, plus recognition award.

他人に腎臓を提供をする人には半年分の給与、一生の健康保険などが提供されるようだ。このようなシステムが推進されるのは、イランの保健制度とも関係がある。

Iran offers lifelong free Hemodialysis treatment to all its citizens with quality standard that of best in the world.

国が透析を無料で提供するシステムになっているため、腎臓移植のインフラを整備することで予算を節約できるようだ。